Product Information
LEVETIRACETAM 500 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0736 per EA under NDC 43547022211. Its NADAC has been published 604 times since Mar 11, 2015.
FDA first approved this application on Feb 10, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547022211
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078106FDA Approved
2/10/2009
TE Code
AB
On Market Since
9/11/2012
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 500 MG TABLET has been published 604 times since Mar 11, 2015, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.1409 (May 13, 2015) |
| All-time low | $0.0608 (Nov 20, 2024) |
| 52-week high | $0.0780 |
| 52-week low | $0.0736 |
| Median price | $0.0988 |
| Average price | $0.1011 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 604 |
| Tracking since | Mar 11, 2015 |
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 500 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0736 per EA (NDC 43547022211), effective Sep 30, 2026.
How has the price of LEVETIRACETAM 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 500 MG TABLET has declined 41.8%. It has been tracked across 604 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 500 MG TABLET?
Since Mar 11, 2015, the NADAC for LEVETIRACETAM 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1409 (May 13, 2015), with a median of $0.0988 per EA.
Are there cheaper alternatives to LEVETIRACETAM 500 MG TABLET?
Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 2% below LEVETIRACETAM 500 MG TABLET.
Who manufactures LEVETIRACETAM 500 MG TABLET?
LEVETIRACETAM 500 MG TABLET (NDC 43547022211) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.